value-based payment model

How hospitals are doing with the CJR program: CMS releases key dataWhile the second feed may not change providers’ actions in terms of the strategy they’re implementing for the Comprehensive Care for Joint Replacement program, the findings should change their expectations.
What does MACRA mean for you? Key takeawaysCMS’ Quality Payment Program (QPP) introduced in the Medicare Access and CHIP Reauthorization Act (MACRA) has created a seismic effect across provider organizations.
Value-Based Payment program presents potential ramificationsOphthalmologists need to prepare their practices for the Value-Based Payment (VBP) program for Medicare services. VBP is a strategy to promote quality and value of health care services, with providers being paid based on value-of-care-delivered rather than volume. Regardless of the perspectives, the fact remains that reimbursement can increase or decrease substantially with the VBP program.
How physicians can negotiate narrow networks
How physicians can negotiate narrow networksLeverage your value.
Weighing value in HER2+ breast cancer treatmentTargeted treatments of HER2-positive breast cancers have dramatically prolonged many patients’ lives. But treatment outcomes in clinical trial settings don’t always translate into comparable real-world clinical value.
10 ways physicians can prepare for value-based payWays physicians can ready their practices for the future of reimbursement.
Can Next Generation ACOs pave the way for value-based pay?The Centers for Medicare & Medicaid Services’ (CMS) shift to alternative physician payments has been a bumpy one. But its newest model, the Next Generation Accountable Care Organization (ACO), aims to smooth the way for healthcare providers looking to make the leap to value-based payments.
Four new oncology payment modelsF. Randy Vogenberg, PhD, partner, Access Market Intelligence, and cofounder National Institute of Collaborative Healthcare, Greenville, S.C., shares insight from AMCP.
CVS, Express Scripts plan value-based drug pricingThe approaches reflect a growing number of initiatives meant to tie drug prices to value. Find out more.
Value-based reimbursement readiness: 3 critical questionsHere are three questions payers must ask to determine providers’ readiness to engage in risk-based reimbursement.